Cardiovasc Res 51(1):2129
Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials
This test evaluates how your body responds to GLP-1 receptor signaling and other peptide pathways, informing whether semaglutide alone, combination therapy with metformin, or alternative compounds like tirzepatide may serve you best
Although early trials indicate potential benefits, widespread adoption requires rigorous evaluation of safety and efficacy
You should also seek advice promptly if you experience ongoing vomiting or diarrhoea, as this can lead to dehydration and may affect kidney function in some patients
This allows the body to safely clear toxic homocysteine while maintaining a continuous, sustainable supply of cysteine for ongoing antioxidant defense